Format

Send to

Choose Destination
Br J Haematol. 2015 Dec;171(5):884-7. doi: 10.1111/bjh.13448. Epub 2015 Apr 8.

CD45 antigen negativity in T-lineage ALL correlates with PTPRC mutation and sensitivity to a selective JAK inhibitor.

Author information

1
Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University, Rome, Italy.
2
Centre for Human Genetics, KU Leuven, Leuven, Belgium.
3
Centre for the Biology of Disease, VIB, Leuven, Belgium.
4
Haematology, Department of Cellular Biotechnologies and Haematology, Sapienza University, Rome, Italy. guarini@bce.uniroma1.it.

KEYWORDS:

CD45 antigen; JAK1 mutation; PTPRC mutation; T-lineage acute lymphoblastic leukaemia; target therapy

PMID:
25854815
DOI:
10.1111/bjh.13448
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center